Global Strategies empowers communities in the most neglected areas of the world to improve the lives of women and children through healthcare.
Joshua is a pediatrician whose primary focus is the care of neonates. He graduated from medical school at Vanderbilt University in 2007 and completed his pediatric residency at the University of California San Francisco.
From 2011-2012 he worked with Global Strategies in the Eastern Congo — continuing our efforts in Pediatric HIV and prevention of HIV transmission from mother to child while expanding into areas of neonatology and severe malnutrition. His passion is to improve the quality of global healthcare by building long-term relationships with frontline clinicians.
While Sloane’s career has primarily focused on working with small, growing companies to implement accounting and management systems, she spent four years managing a medical equipment company in Mill Valley. Her passion for community service led her to seek out volunteer work with local nonprofits and eventually her professional career transitioned to nonprofit operations. She has been married for 23 years and has a son and a daughter in college.
Jean provides education and training to partners on data and technology solutions to help them care for their patients. She is passionate about using technology and data to help improve the lives of women and children. Jean has worked in research and management roles in emerging health care technologies, chronic disease, patient education, and women's health. She is active in the American Public Health Association's International Health section leadership and enjoys mentoring public health students. Jean has a B.A. in Economics from San Francisco State University and a Master of Public Health in Applied Epidemiology from Emory University.
Elon is a technologist passionate about health, education, and design. He is thrilled that his interests intersect at Global Strategies, with its innovative technology programs for nurses who make crucial decisions about neonatal and maternal health. Elon has experience designing and building mobile health apps, as well as contributing to design and development teams at a range of organizations, from startups to large companies like Autodesk. A Stanford graduate, he lives near San Francisco with his wife and young daughter.
Sabrina Smith is a leadership and audience engagement professional within the global nonprofit community. Since 2016, she has been managing the communications, marketing and donor engagement at Global Strategies including overseeing the organization’s annual outreach plan, using an integrated multi-platform approach. Sabrina loves looking for and sharing out the many incredible stories from our field partners and students in training. Through this storytelling, she focuses on increasing the awareness and impact of our work, and growing our donor base.
Sabrina has a B.S. in Business Administration from Dominican University of California and sits on the International Advisory Board at the Art Science Museum in Singapore.
Dr. Givano Kashemwa has worked as the Global Strategies Country Program Director in the Democratic Republic of Congo since 2010. Prior to joining Global Strategies, he had worked at Médecins Sans Frontières (Doctors without Borders) and helped introduce HIV care in the South Kivu Province. He graduated from medical school at Bukavu University in 2001 and completed his public health degree, also at Bukavu University, in 2012. His passion is to develop and improve service delivery models and the quality of data collected in collaboration with in-country partners and Global Strategies.
In June 2011 Nicole started Impact Solutions. Nicole Rubin was CEO of Ronald McDonald House Charities of Southern California (RMHCSC) from 2006 to June 2011. As CEO, Nicole was responsible for ensuring the organization meets its mission of providing comfort, care and support to children and families in Southern California.
To achieve this mission, Nicole oversaw operations, development and continued growth of all of RMHCSC’s programs, including four Ronald McDonald Houses in Loma Linda, Los Angeles, Orange and Pasadena, with a fifth one opened in 2011 in Long Beach; Camp Ronald McDonald for Good Times in Idyllwild; a community grants board and four scholarship programs.
Prior to joining RMHCSC, Nicole was the executive director at the Susan G. Komen Breast Cancer Foundation in New York City where she led the development and implementation of plans to assure continued growth, visibility and advancement of breast cancer programs and services.
Nicole has more than ten years of experience in health care, non-profit management and fund-raising. Prior to her work with the Komen Foundation, she worked for the Methodist Health Care System in Houston as the assistant vice president of Planning, Marketing and Corporate Communications.
Dr. Ruel co-founded IPOP (The International Pediatric Outreach Project, which merged to become Global Strategies) with Dr. Sadath Sayeed in 2002, while completing his training in pediatrics at the University of California, San Francisco. He went on to pursue training in pediatric infectious disease and joined the UCSF faculty in 2009. Dr. Ruel is now Chief of the Division of Pediatric Infectious Diseases and Global Health in 2018. He provides clinical care for children and young adults with HIV in San Francisco. He also performs clinical and implementation research to improve the care of newborns, and children living with HIV globally.
See Founders for more details.
Dr. Duliege is a clinical assistant professor at the Lucile Packard Children’s Hospital at Stanford, and a senior executive with over 25 years of experience in the biopharmaceutical industry. She has served on the Board of Global Strategies since 2010 and was appointed chairperson of the BOD in 2015.
Dr. Duliege has extensive experience in infectious diseases and immunology and has long been associated with many aspects of the fight against AIDS. She initially focused on understanding the transmission of HIV from mother to child and then participated in the testing of HIV drugs and potential vaccines, first at Genentech and then at Chiron. In these endeavors, she has collaborated with the National Institute of Health, the Army, several companies, and many medical centers in the U.S. and around the world. She is now Chief Medical Officer at Rigel, a biopharmaceutical company focusing on the development of treatments for auto-immune diseases. Dr. Duliege continues to practice pediatrics as a Clinical Assistant Professor in the Department of Pediatrics Rheumatology at the Lucille Packard Children's Hospital at Stanford. She also serve on the board of CIRM, the California Institute for Regenerative Medicine (stem cell research), and on the board of AVAC, the AIDS Vaccine Advocacy Coalition, another non for profit organization focused on HIV prevention efforts.
She has an MS in Epidemiology from Harvard School of Public Health, an MS in Biostatistics, a Doctorate in Medicine and a Board Certification in Pediatrics from Paris Hospitals.
Joseph (“Mike”) McCune is a Professor of Medicine at the University of California, San Francisco. His lab has been involved for many years in the analysis of HIV pathogenesis, prevention, treatment, and cure.
After studies at Harvard College, Cornell University Medical College, and The Rockefeller University, Dr. McCune started to treat patients with HIV disease as a resident in internal medicine at UCSF in 1982, and he has been involved in the HIV/AIDS research field ever since. This work included postdoctoral studies at Stanford, exploring the fusogenic properties of the HIV envelope protein and developing the first humanized mouse model (the SCID-hu mouse) capable of multilineage human hematopoiesis and receptive to infection with primary isolates of HIV. He then co-founded the companies SyStemix (in 1988) and Progenesys (and 1991), serving as Scientific Director and leading research efforts to find better ways – including antiviral medications and hematopoietic stem cell-based gene therapy – to treat HIV disease.
In 1995, Dr. McCune returned to academia, first as an investigator at the Gladstone Institute of Virology and Immunology and then (starting in 2006) as the Chief of the Division of Experimental Medicine (which he founded) at UCSF. Concomitantly, he was the founding PI (and Senior Associate Dean) of the Clinical and Translational Sciences Institute at UCSF (from 2005-08). In recent years, he has helped to form multidisciplinary, collaborative research teams to find a cure for HIV disease. Throughout this time, he has actively mentored graduate students and postdoctoral fellows, many of whom have gone on to successful careers in academia or biotech/pharma. He has served as a board member for a variety of non-profit organizations, including the Elizabeth Glaser Pediatric AIDS Foundation, Project Inform, Project Open Hand, The Rockefeller University, the Gay Men’s Health Crisis, the Foundation for AIDS and Immune Research, the Foundation for Vaccine Research, the Alliance for Lupus Research, the Immune Tolerance Network, the Bluefield Project to Cure Frontotemporal Dementia, and for the biotechnology companies, SyStemix, Progenesys, and Prosetta.
Dr. Elizabeth Rogers is an Associate Professor of Pediatrics at University of California San Francisco; practices neonatology in the Intensive Care Nursery (ICN); and is the Director of the ROOTS Program, The Grove Small Baby Unit, and the ICN Follow Up Program at UCSF. Her clinical expertise is in prematurity, periviable birth and decision-making, neuroprotection, developmental care, palliative care, family-centered care and advocacy, and long-term neurodevelopmental outcomes after neonatal critical illness. She has led follow up efforts for multicenter trials involving preterm and term infants at risk for pulmonary and neurodevelopmental impairment, has peer-reviewed manuscripts and chapters focused on mortality and morbidity after neonatal critical illness, and serves on statewide and national quality improvement collaboratives. She received an AB in Slavic Languages and Literatures and History of Science at Harvard University and received her medical degree from Stanford University. She received pediatric and neonatal-perinatal subspecialty training at UCSF.
Dr. Ammann has a long and distinguished career in pediatric immunology and infectious disease.
In 1977 he performed the clinical trials that led to the first approval for a pneumococcal vaccine. In 1982, Dr. Ammann described two of the three ways that HIV is transmitted. In 1998, he founded Global Strategies for HIV Prevention, which became Global Strategies in 2013.
He has authored or co-authored over 450 scientific papers and given over 700 international lectures and courses on HIV/AIDS. He is a Clinical Professor of Pediatrics at the University of California, San Francisco.
See Founders for more details.
Dr. Eric Goosby served as the United States Global AIDS Coordinator, leading all U.S. Government international HIV/AIDS efforts. In this role, Ambassador Goosby oversaw implementation of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), as well as U.S. Government engagement with the Global Fund to Fight AIDS, Tuberculosis and Malaria. He serves on the Operations Committee that leads the U.S. Global Health Initiative, along with the heads of the U.S. Agency for International Development and the Centers for Disease Control and Prevention. PEPFAR is the cornerstone of the Global Health Initiative, which takes a comprehensive approach to strengthen health systems and improve health outcomes in the developing world.
Dr. Goosby is currently leading a new center on implementation sciences at UCSF, as well as seeing patients on Ward 86 at San Francisco General Hospital and Trauma Center, where he worked in the early days of the HIV/AIDS epidemic.